News | October 12, 2024
Akums launches dual action heartburn relief chewable tablet
This product is categorized as antacids, antiflatulents and anti-Ulcerants
This product is categorized as antacids, antiflatulents and anti-Ulcerants
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis
We now rank 3rd in pharmaceutical production by volume and 14th by value
Biotin Sublingual Spray and Melatonin Sublingual Spray to help consumers tackle health issues that come with today’s fast-paced life
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
Strategic focus on COCO-model with a nationwide reach of 501 stores
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
Subscribe To Our Newsletter & Stay Updated
